Dataset Information


Europium (III) chelate microparticle-based lateral flow immunoassay strips for rapid and quantitative detection of antibody to hepatitis B core antigen.

ABSTRACT: Quantitative hepatitis B core antigen (anti-HBc) measurements could play an important role in evaluating therapeutic outcomes and optimizing the antiviral therapy of chronic hepatitis B infection. In this study, we have developed a simple and rapid fluorescence point-of-care test based on a lateral flow immunoassay (LFIA) method integrated with Eu (III) chelate microparticles to quantitatively determine anti-HBc concentrations in serum. This assay is based on a direct competitive immunoassay performed on lateral flow test strips with an assay time of 15?min. The Eu (III) chelate microparticle-based LFIA assay could quantitatively detect anti-HBc levels with a limit of detection of 0.31 IU mL-1, and exhibited a wide linear range (0.63-640 IU mL-1). The intra- and inter-assay coefficients of variation for anti-HBc were both less than 10% and a satisfactory dilution test and accuracy were demonstrated. There were no statistically significant differences in sensitivity or specificity in serum samples between the Eu (III) chelate microparticle-based LFIA strips and the Abbott Architect kit. A simple, rapid and effective quantitative detection of anti-HBc was possible using the Eu (III) chelate microparticle-based LFIA strips. The strips will provide diagnostic value for clinical application.


PROVIDER: S-EPMC5658374 | BioStudies | 2017-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

2020-01-01 | S-EPMC7086788 | BioStudies
1000-01-01 | S-EPMC6338966 | BioStudies
2020-01-01 | S-EPMC7677456 | BioStudies
1000-01-01 | S-EPMC4985618 | BioStudies
1000-01-01 | S-EPMC3009253 | BioStudies
2017-01-01 | S-EPMC5421713 | BioStudies
2021-01-01 | S-EPMC7953718 | BioStudies
2013-01-01 | S-EPMC3707427 | BioStudies
2018-01-01 | S-EPMC5990927 | BioStudies
2008-01-01 | S-EPMC3780777 | BioStudies